DL-Ofloxacin
Also known as HOE-280, DL-8280, OFLX, 8-fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid, Floxin, (+/-)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, (+/-)-ofloxacin
Antibiotikum
Key facts
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 462264606
- Drug.image
- Ofloxacin.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 240
- Drug.chirality
- Racemic mixture
- Drug.image2
- Ofloxacin zwitterion ball from xtal.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Floxin, Ocuflox, others
- Drug.MedlinePlus
- a691005
- Drug.DailyMedID
- Ofloxacin
- Drug.routes_of_administration
- By mouth, intravenous therapy, topical (eye drops and ear drops)
Article · Deutsch
Ofloxacin ist ein Antibiotikum aus der Gruppe der Fluorchinolone, das 1982 von Daiichi Sankyō patentiert wurde.
Abstract from DBpedia / Wikipedia · CC BY-SA
Gallery (3)
Connections
Categories
1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids4-Methylpiperazin-1-yl compoundsCyclic ethersDaiichi SankyoDrugboxes which contain changes to watched fieldsDrugs developed by AbbVieDrugs developed by Johnson & JohnsonECHA InfoCard ID from WikidataFluoroquinolone antibioticsGABAA receptor negative allosteric modulatorsOphthalmology drugs